InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in InflaRx N.V. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −5 vs. Q1 2021
- Shares held
- 11.2M
- −3.29M (−22.8%) vs. Q1 2021
- Total value
- $33.1M
- −$23.2M (−41.2%) vs. Q1 2021
- New holders
- 5
- 4 more added
- Sold out
- 10
- 15 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 30 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,245 | $4.00K | 0.00% | −5,284−80.9% | Reduced |
| Steward Partners Investment Advisory, LLC | 1,200 | $4.00K | 0.00% | −250−17.2% | Reduced |
| Simplex Trading, LLC | 3,846 | $11.0K | 0.00% | −1,014−20.9% | Reduced |
| BlackRock Inc. | 7,419 | $22.0K | 0.00% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 10,762 | $32.0K | 0.00% | −315−2.8% | Reduced |
| Citadel Advisors LLC | 10,836 | $32.0K | 0.00% | +10,836 | New |
| Personal Cfo Solutions, LLC | 11,000 | $33.0K | 0.01% | −2,000−15.4% | Reduced |
| ETF Managers Group, LLC | 12,931 | $38.0K | 0.00% | −395−3.0% | Reduced |
| Raymond James & Associates | 19,919 | $59.0K | 0.00% | −21,574−52.0% | Reduced |
| Pacifica Partners Inc. | 20,585 | $61.0K | 0.05% | +8,000+63.6% | Added |
| Algert Global LLC | 23,010 | $68.0K | 0.02% | −11,630−33.6% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 23,346 | $69.0K | 0.00% | −3,698−13.7% | Reduced |
| IPG Investment Advisors LLC | 25,900 | $76.9K | 0.02% | +25,900 | New |
| Millennium Management LLC | 32,542 | $97.0K | 0.00% | +2,027+6.6% | Added |
| Marquette Asset Management, LLC | 33,215 | $99.0K | 0.02% | +33,215 | New |
| Susquehanna International Group, LLP | 33,664 | $100.0K | 0.00% | −25,807−43.4% | Reduced |
| Gsa Capital Partners LLP | 46,633 | $139.0K | 0.02% | +46,633 | New |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 49,800 | $148.0K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 70,000 | $208.0K | 0.12% | 00.0% | Unchanged |
| Franklin Street Advisors Inc | 75,100 | $223.0K | 0.02% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 84,900 | $252.0K | 0.01% | −4,223−4.7% | Reduced |
| Verition Fund Management LLC | 85,761 | $255.0K | 0.00% | −30,934−26.5% | Reduced |
| Renaissance Technologies LLC | 134,283 | $399.0K | 0.00% | +10,936+8.9% | Added |
| Altium Capital Management LP | 161,206 | $479.0K | 0.11% | −613,394−79.2% | Reduced |
| QS Investors, LLC | 174,200 | $517.0K | 0.01% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 197,643 | $587.0K | 0.00% | +197,643 | New |
| FNY Investment Advisers, LLC | 343,000 | $1.02M | 0.41% | −7,000−2.0% | Reduced |
| Kingdon Capital Management, L.L.C. | 400,000 | $1.19M | 0.18% | 00.0% | Unchanged |
| Laurion Capital Management LP | 500,000 | $1.49M | 0.02% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 600,000 | $1.78M | 0.37% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 666,596 | $1.98M | 0.35% | −33,154−4.7% | Reduced |
| Morgan Stanley | 751,293 | $2.23M | 0.00% | +30,316+4.2% | Added |
| OrbiMed Advisors LLC | 1,064,118 | $3.16M | 0.03% | 00.0% | Unchanged |
| Great Point Partners LLC | 2,200,000 | $6.53M | 1.46% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,285,000 | $9.76M | 0.15% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −836,881−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −381,086−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −268,634−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −138,040−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −110,573−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,020−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |